Science and Enterprise

Tag: NIH

  • U.S. Cancer Care Costs to Rise 39 Pct by 2020

    The cost of caring for U.S. cancer patients is expected to rise sharply in the 2010 to 2020 decade, according to an analysis published online in the Journal of the National Cancer Institute. The combination of population aging and rising expense rates are projected to push the cost for cancer care to $173 billion, a…

  • Arthritis Drug Protects Against Non-Melanoma Skin Cancer

    A widely used arthritis drug reduces the incidence of non-melanoma skin cancers according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib, approved for the treatment of osteoarthritis, rheumatoid arthritis, and acute pain in adults, led to a 62 percent reduction in non-melanoma skin cancers, which…

  • Study Shows Drug Combo Effective as HIV Prevention

    A new study called iPrEx shows that individuals at high risk for HIV infection who took a once-a-day commercially-available tablet containing two widely used HIV medications experienced fewer HIV infections than those who received a placebo pill. The researchers say that the clinical trial, reported in the New England Journal of Medicine, is the first…

  • Research Institutes Collaborate on Cancer Nanomedicine

    Five research institutions have formed the Texas Center for Cancer Nanomedicine (TCCN) in Houston to develop nanotechnologies to improve outcomes for patients with ovarian or pancreatic cancers. TCCN is funded by a five-year, $16 million grant from National Cancer Institute. The five institutions taking part in TCCN include University of Texas MD Anderson Cancer Center,…

  • IRS Posts Therapeutic Discovery Project Awards

    The Internal Revenue Service (IRS) posted the complete list of companies receiving Qualifying Therapeutic Discovery Project credits and grants under a provision of the Affordable Care Act enacted on 23 March 2010. The Qualifying Therapeutic Discovery Project program is targeted to projects that show potential to produce new therapies, reduce long-term health care costs, or…

  • Small Business Grants to Develop Personalized Cancer Tests

    20/20 GeneSystems Inc. in Rockville, Maryland said today that the company has received nearly $3 million in two grants from the National Cancer Institute (NCI) to develop tests for helping oncologists predict the effectiveness of targeted cancer therapies. The grants were awarded under NCI’s Small Business Innovative Research (SBIR) Program. 20/20 says more than 20…

  • Grant Funds Company Clinical Trial of Addiction Drug

    Omeros Corporation, a biopharmaceutical company  in Seattle, Washington, said today that the National Institute on Drug Abuse (NIDA), part of National Institutes of Health, has provided an additional grant to fund clinical studies for the company’s addiction program. The grant will fund a clinical trial of the company’s drug on addiction to heroin and cigarettes.…

  • Virginia Medical Device Company Wins Small Business Grants

    HemoSonics LLC, a developer of blood diagnostics devices in Charlottesville, Virginia, has received three grants totaling some $2 million from National Institutes of Health (NIH) and Office of Naval Research. The company was founded by three faculty members at University of Virginia, also in Charlottesville, to commercialize their research in biomedical engineering. HemoSonics’ technology, called…

  • FDA, NIH Award Grant to Study Adaptive Clinical Trial Design

    Researchers from academia and business aim to improve the process for testing therapies and medical devices by investigating a new type of clinical trial called adaptive clinical trials. This kind of clinical study makes adjustments to the trial using information accumulated as patients are enrolled, with the goal of improving clinical trials’ efficiency as a…

  • Three Companies Win NIH Biodefense Research Contracts

    The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, awarded three new contracts to fund research on vaccines and vaccine delivery against dengue fever and anthrax that could be used in a terror attack. Total funding for the three contracts could reach $68 million, depending on the successful…